Fast Locator 2012-2013: Abbott Laboratories - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fast Locator 2012-2013: Abbott Laboratories


Abbott Laboratories Outsourcing Services

Abbott Laboratories
1401 Sheridan Road
North Chicago, IL 60064
tel. 847.938.8524, 800.240.1043
fax 847.937.9706
Website: www.abbottcontractmfg.com
Email: ebu.abt@abbott.com


Sales Contact:

Amy Kutilek

Year Founded:

1888

Regions where services are provided:

North America, Asia, Europe.

Number of Employees:

501+

Annual Revenues:

$500 million+

Outsourcing services provided:

Biomanufacturing

  • Cell culture

Commercial Manufacturing

  • Ingredient processing
  • Injectables manufacturing
  • API manufacturing (cGMP, large molecules/biologics)
  • API & advanced intermediates manufacturing (cGMP, small molecule)

Packaging and Logistics

  • Commercial packaging

API Production Technologies

  • High-potency or high-containment manufacturing

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
33%
Breakthrough designations
17%
Protecting the supply chain
50%
Expedited reviews of drug submissions
0%
More stakeholder involvement
0%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
Report: Pfizer Makes $101 Billion Offer to AstraZeneca

Click here